Alex Elder

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia.

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia.

Journal: Blood
Published: December 03, 2021

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.

Journal: Cancer cell
Published: April 17, 2019

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.

Journal: Cancer cell
Published: November 29, 2017

Epidemiology and biology of relapse after stem cell transplantation.

Epidemiology and biology of relapse after stem cell transplantation.

Journal: Bone marrow transplantation
Published: August 23, 2017

Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia.

Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia.

Journal: Leukemia
Published: November 18, 2016

BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance.

BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance.

Journal: Leukemia
Published: April 09, 2016

The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.

The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.

Journal: Blood
Published: August 26, 2015

Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia.

Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia.

Journal: Leukemia
Published: August 05, 2015

CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia.

CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia.

Journal: Pediatric blood & cancer
Published: October 22, 2014

Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia.

Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia.

Journal: Leukemia
Published: November 14, 2013

Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression.

Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression.

Journal: Leukemia
Published: August 04, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026